PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.4750
0.00 (0.00%)
Oct 1, 2025, 11:59 AM EDT

PharmaCorp Rx Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
13.915.79---
Cost of Revenue
8.453.61---
Gross Profit
5.462.18---
Selling, General & Admin
5.393.20.580.180.08
Operating Expenses
6.323.770.580.560.08
Operating Income
-0.86-1.59-0.58-0.56-0.08
Interest Expense
-0.04-0.01---
Interest & Investment Income
0.530.380.110.050
Other Non Operating Income (Expenses)
0.140.06---
Pretax Income
-0.23-1.16-0.47-0.52-0.08
Income Tax Expense
0.16-0.11---
Earnings From Continuing Operations
-0.39-1.05-0.47-0.52-0.08
Minority Interest in Earnings
0.030.04---
Net Income
-0.36-1.01-0.47-0.52-0.08
Net Income to Common
-0.36-1.01-0.47-0.52-0.08
Shares Outstanding (Basic)
11682202016
Shares Outstanding (Diluted)
11682202016
Shares Change (YoY)
20.45%303.02%1.39%23.69%-
EPS (Basic)
-0.00-0.01-0.02-0.03-
EPS (Diluted)
-0.00-0.01-0.02-0.03-
Free Cash Flow
-1.730.12-0.52-0.120
Free Cash Flow Per Share
-0.010.00-0.03-0.01-
Gross Margin
39.25%37.69%---
Operating Margin
-6.18%-27.41%---
Profit Margin
-2.57%-17.48%---
Free Cash Flow Margin
-12.45%2.04%---
EBITDA
-0.31-1.35---
EBITDA Margin
-2.22%-23.23%---
D&A For EBITDA
0.550.24---
EBIT
-0.86-1.59-0.58-0.56-0.08
EBIT Margin
-6.18%-27.41%---
Revenue as Reported
---0.050
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.